Correlation Between HLS Therapeutics and Canntab Therapeutics
Can any of the company-specific risk be diversified away by investing in both HLS Therapeutics and Canntab Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HLS Therapeutics and Canntab Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HLS Therapeutics and Canntab Therapeutics Limited, you can compare the effects of market volatilities on HLS Therapeutics and Canntab Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HLS Therapeutics with a short position of Canntab Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HLS Therapeutics and Canntab Therapeutics.
Diversification Opportunities for HLS Therapeutics and Canntab Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between HLS and Canntab is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding HLS Therapeutics and Canntab Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Canntab Therapeutics and HLS Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HLS Therapeutics are associated (or correlated) with Canntab Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Canntab Therapeutics has no effect on the direction of HLS Therapeutics i.e., HLS Therapeutics and Canntab Therapeutics go up and down completely randomly.
Pair Corralation between HLS Therapeutics and Canntab Therapeutics
If you would invest 253.00 in HLS Therapeutics on October 21, 2024 and sell it today you would earn a total of 7.00 from holding HLS Therapeutics or generate 2.77% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 90.48% |
Values | Daily Returns |
HLS Therapeutics vs. Canntab Therapeutics Limited
Performance |
Timeline |
HLS Therapeutics |
Canntab Therapeutics |
HLS Therapeutics and Canntab Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with HLS Therapeutics and Canntab Therapeutics
The main advantage of trading using opposite HLS Therapeutics and Canntab Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HLS Therapeutics position performs unexpectedly, Canntab Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Canntab Therapeutics will offset losses from the drop in Canntab Therapeutics' long position.HLS Therapeutics vs. Aion Therapeutic | HLS Therapeutics vs. Cannara Biotech | HLS Therapeutics vs. Knight Therapeutics | HLS Therapeutics vs. Canntab Therapeutics Limited |
Canntab Therapeutics vs. Bionoid Pharma | Canntab Therapeutics vs. CTT Pharmaceutical Holdings | Canntab Therapeutics vs. Alterola Biotech | Canntab Therapeutics vs. HLS Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |